Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 74.6 | 58.9 | 44.0 | 42.9 | 48.3 |
| Revenue growth | 26.6% | 33.7% | 2.8% | -11.3% | |
| Cost of goods sold | 29.1 | 26.0 | 22.1 | 20.7 | 24.0 |
| Gross profit | 45.5 | 32.9 | 21.9 | 22.2 | 24.4 |
| Gross margin | 61.0% | 55.8% | 49.8% | 51.8% | 50.4% |
| Selling, general and administrative | 7.3 | 7.1 | 8.3 | 6.1 | 2.9 |
| Research and development | 2.6 | 1.9 | 2.4 | 1.9 | |
| General and administrative | 2.2 | 2.0 | 3.6 | 2.6 | |
| EBIT | 35.6 | 23.9 | 11.2 | 14.2 | 21.5 |
| EBIT margin | 47.7% | 40.5% | 25.5% | 33.2% | 44.4% |
| Pre-tax income | 29.9 | 18.5 | 6.2 | 9.6 | 11.7 |
| Income taxes | 8.8 | 5.1 | 1.9 | 2.6 | 3.0 |
| Tax rate | 29.4% | 27.6% | 31.0% | 27.4% | 25.8% |
| Net income | 21.1 | 13.4 | 4.3 | 7.0 | 8.7 |
| Net margin | 28.3% | 22.7% | 9.8% | 16.3% | 18.0% |
| |
| Diluted EPS | $2.51 | $1.61 | $0.53 | $0.86 | $0.00 |
| Shares outstanding (diluted) | 8.4 | 8.3 | 8.2 | 8.1 | 7,317.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|